Diabetes Action Research and Education Foundation Report issue

Foundation

Organization Overview

First Clinical Trial
2010
NCT01524874
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

insulin human (humulin) (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2